H1N1 Influenza: Critical Care Aspects

Glen P Westall; Miranda Paraskeva

doi:10.1055/s-0031-1283280

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2011; 32(4): 400-408
DOI: 10.1055/s-0031-1283280

H1N1 Influenza: Critical Care Aspects

Glen P. Westall¹ , Miranda Paraskeva¹

¹Department of Allergy, Immunology, and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia

Abstract

ABSTRACT

During the Northern Hemisphere spring of 2009, a novel H1N1 influenza A virus emerged in Mexico, causing widespread human infection and acute critical respiratory illness. The 2009 H1N1 virus spread initially to the United States and Canada, with subsequent rapid global dissemination, leading the World Health Organization (WHO) to declare “a public health emergency of international concern” in April 2009, and upgrading the viral threat to pandemic status in June 2009. Despite initial fears, the severity of the 2009 H1N1 pandemic overall did not differ significantly from that of seasonal influenza. However, the demographics of those at risk of severe illness did differ (affecting children and young adults, rather than the very young and the very old). The 2009 H1N1 pandemic led to rapid implementation of health care initiatives, including the provision of critical care services, to limit the effect of the influenza outbreak on the community. This review focuses on the critical care response to the H1N1 pandemic and examines whether the implementation of critical care services as planned a priori matched the reality of the clinical workload and the patient burden that transpired during the 2009 H1N1 influenza pandemic.

KEYWORDS

H1N1 - novel H1N1 influenza - influenza - pandemic

Full Text

References

REFERENCES

1 Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S INER Working Group on Influenza et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009; 361 (7) 680-689
2 Garten R J, Davis C T, Russell C A et al.. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009; 325 (5937) 197-201
3 Murray J F, Matthay M A, Luce J M, Flick M R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988; 138 (3) 720-723
4 de Castro I F, Guzmán-Fulgencio M, García-Alvarez M, Resino S. First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1. Crit Care. 2010; 14 (1) 115
5 Maines T R, Jayaraman A, Belser J A et al.. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science. 2009; 325 (5939) 484-487
6 Itoh Y, Shinya K, Kiso M et al.. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009; 460 (7258) 1021-1025
7 Munster V J, de Wit E, van den Brand J M et al.. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science. 2009; 325 (5939) 481-483
8 Khan K, Arino J, Hu W et al.. Spread of a novel influenza A (H1N1) virus via global airline transportation. N Engl J Med. 2009; 361 (2) 212-214
9 WHO flu update. 2010. http://wwwwhoint/csr/don/2010_06_04/en/indexhtml Accessed June 5, 2010
10 Chowell G, Bertozzi S M, Colchero M A et al.. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009; 361 (7) 674-679
11 Simonsen L, Olson D R, Viboud C, Taylor R J, Miller M A, Reichert T. Pandemic influenza and mortality: past evidence and projection for the future. In: Knobler S L, Mack A, Mahmoud A, Lemon S M, eds. The Threat of Pandemic Influenza: Are We Ready?. Washington, DC: National Academies Press; 2005: 89-114
12 Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2009; 84 (46) 481-484
13 Louie J K, Acosta M, Winter K California Pandemic (H1N1) Working Group et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009; 302 (17) 1896-1902
14 Francis T. On the doctrine of original antigenic sin. Proc Am Philos Soc. 1960; 104 572-578
15 Jain S, Kamimoto L, Bramley A M 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009; 361 (20) 1935-1944
16 Domínguez-Cherit G, Lapinsky S E, Macias A E et al.. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009; 302 (17) 1880-1887
17 Webb S A, Pettilä V, Seppelt I ANZIC Influenza Investigators et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009; 361 (20) 1925-1934
18 Kumar A, Zarychanski R, Pinto R Canadian Critical Care Trials Group H1N1 Collaborative et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009; 302 (17) 1872-1879
19 Wilson N, Baker M G. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill. 2009; 14 (26)
20 Thompson W W, Shay D K, Weintraub E et al.. Influenza-associated hospitalizations in the United States. JAMA. 2004; 292 (11) 1333-1340
21 Cao B, Li X W, Mao Y National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009; 361 (26) 2507-2517
22 Libster R, Bugna J, Coviello S et al.. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2010; 362 (1) 45-55
23 Jouvet P, Hutchison J, Pinto R Canadian Critical Care Trials Group H1N1 Collaborative et al. Critical illness in children with influenza A/pH1N1 2009 infection in Canada. Pediatr Crit Care Med. 2010; 11 (5) 603-609
24 Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. Wkly Epidemiol Rec. 2009; 85 (6) 37-40
25 Miroballi Y, Baird J S, Zackai S et al.. Novel influenza A(H1N1) in a pediatric health care facility in New York City during the first wave of the 2009 pandemic. Arch Pediatr Adolesc Med. 2010; 164 (1) 24-30
26 Lister P, Reynolds F, Parslow R et al.. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet. 2009; 374 (9690) 605-607
27 Centers for Disease Control and Prevention (CDC) . Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection—United States, April–August 2009. MMWR Morb Mortal Wkly Rep. 2009; 58 (34) 941-947
28 Funk D J, Siddiqui F, Wiebe K et al.. Practical lessons from the first outbreaks: clinical presentation, obstacles, and management strategies for severe pandemic (pH1N1) 2009 influenza pneumonitis. Crit Care Med. 2010; 38 (4, Suppl) e30-e37
29 Miller III R R, Markewitz B A, Rolfs R T et al.. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest. 2010; 137 (4) 752-758
30 Neuzil K M, Reed G W, Mitchel E F, Simonsen L, Griffin M R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998; 148 (11) 1094-1102
31 Lapinsky S E. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med. 2010; 38 (4, Suppl) e52-e57
32 2009 H1N1 flu: international situation update. Atlanta, GA: Centers for Disease Control and Prevention; 2009. http://www.cdc.gov/h1n1flu/updates/international Accessed June 5, 2010
33 Louie J K, Acosta M, Jamieson D J, Honein M A. California Pandemic (H1N1) Working Group . Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010; 362 (1) 27-35
34 Jamieson D J, Honein M A, Rasmussen S A Novel Influenza A (H1N1) Pregnancy Working Group et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009; 374 (9688) 451-458
35 ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System . Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010; 340 c1279
36 Flint S M, Davis J S, Su J Y et al.. Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory. Med J Aust. 2010; 192 (10) 617-622
37 Kunisaki K M, Janoff E N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis. 2009; 9 (8) 493-504
38 Australian Health Management Plan for Pandemic Influenza 2009 (AHMPPI 2009). http://www.health.gov.au/internet/panflu/publishing.nsf/Content/resources-1#ahmppi Accessed June 5, 2010
39 Australian Government Department of Health and Ageing .Australian influenza surveillance report no. 21: reporting period 26 September–2 October 2009. http://www.healthemergency.gov.au Accessed June 5, 2010
40 Funk D J, Siddiqui F, Wiebe K et al.. Practical lessons from the first outbreaks: clinical presentation, obstacles, and management strategies for severe pandemic (pH1N1) 2009 influenza pneumonitis. Crit Care Med. 2010; 38 (4, Suppl) e30-e37
41 Cauchemez S, Donnelly C A, Reed C et al.. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med. 2009; 361 (27) 2619-2627
42 Louie J K, Acosta M, Jamieson D J, Honein M A. California Pandemic (H1N1) Working Group . Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010; 362 (1) 27-35
43 WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Geneva, Switzerland: World Health Organization; 2010. http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/index.html Accessed June 5, 2010
44 Ariano R E, Sitar D S, Zelenitsky S A et al.. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ. 2010; 182 (4) 357-363
45 Wang B, Dwyer D E, Blyth C C et al.. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res. 2010; 87 (1) 16-21
46 Dulek D E, Williams J V, Creech C B et al.. Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clin Infect Dis. 2010; 50 (11) 1493-1496
47 Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. Geneva, Switzerland: World Health Organization; November 2009. http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/index.html Accessed June 5, 2010
48 Danziger-Isakov L A, Husain S, Mooney M L, Hannan M M. ISHLT Infectious Diseases Council . The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant. 2009; 28 (12) 1341-1347
49 Kumar D, Morris M I, Kotton C N AST Infectious Diseases Community of Practice and Transplant Infectious Diseases Section of TTS et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant. 2010; 10 (1) 18-25
50 Quispe-Laime A M, Bracco J D, Barberio P A et al.. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med. 2010; 36 (1) 33-41
51 Stockman L J, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006; 3 (9) e343
52 Sprung C L, Annane D, Singer M, Cuthbertson B H, Briegel J. Steroids in patients with septic shock. Chest. 2009; 136 (1) 323-324 author reply 324
53 Wright P F, Kirkland K B, Modlin J F. When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia. N Engl J Med. 2009; 361 (24) e112
54 Morens D M, Taubenberger J K, Fauci A S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008; 198 (7) 962-970
55 Kesecioglu J, Beale R, Stewart T E et al.. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2009; 180 (10) 989-994
56 Adhikari N, Burns K E, Meade M O. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev. 2004; (4) CD004477
57 Raghavendran K, Pryhuber G S, Chess P R, Davidson B A, Knight P R, Notter R H. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr Med Chem. 2008; 15 (19) 1911-1924
58 Adhikari N K, Burns K E, Friedrich J O, Granton J T, Cook D J, Meade M O. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007; 334 (7597) 779
59 Hilbert G, Gruson D, Vargas F et al.. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001; 344 (7) 481-487
60 Lightowler J V, Wedzicha J A, Elliott M W, Ram F S. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ. 2003; 326 (7382) 185
61 Masip J, Roque M, Sánchez B, Fernández R, Subirana M, Expósito J A. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA. 2005; 294 (24) 3124-3130
62 Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med. 2003; 168 (12) 1438-1444
63 Agarwal R, Reddy C, Aggarwal A N, Gupta D. Is there a role for noninvasive ventilation in acute respiratory distress syndrome? A meta-analysis. Respir Med. 2006; 100 (12) 2235-2238
64 Hui D S, Ip M, Tang J W et al.. Airflows around oxygen masks: a potential source of infection?. Chest. 2006; 130 (3) 822-826
65 Miller III R R, Markewitz B A, Rolfs R T et al.. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest. 2010; 137 (4) 752-758
66 Ramsey C D, Funk D, Miller III R R, Kumar A. Ventilator management for hypoxemic respiratory failure attributable to H1N1 novel swine origin influenza virus. Crit Care Med. 2010; 38 (4, Suppl) e58-e65
67 Kolobow T, Moretti M P, Fumagalli R et al.. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation: an experimental study. Am Rev Respir Dis. 1987; 135 (2) 312-315
68 Brower R G, Lanken P N, MacIntyre N National Heart, Lung, and Blood Institute ARDS Clinical Trials Network et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004; 351 (4) 327-336
69 Bulger E M, Jurkovich G J, Gentilello L M, Maier R V. Current clinical options for the treatment and management of acute respiratory distress syndrome. J Trauma. 2000; 48 (3) 562-572
70 Amato M B, Barbas C S, Medeiros D M et al.. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998; 338 (6) 347-354
71 Meade M O, Cook D J, Guyatt G H Lung Open Ventilation Study Investigators et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008; 299 (6) 637-645
72 Mercat A, Richard J C, Vielle B Expiratory Pressure (Express) Study Group et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008; 299 (6) 646-655
73 The HIFI Study Group . High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med. 1989; 320 (2) 88-93
74 Piedalue F, Albert R K. Prone positioning in acute respiratory distress syndrome. Respir Care Clin N Am. 2003; 9 (4) 495-509
75 Gattinoni L, Tognoni G, Pesenti A Prone-Supine Study Group et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001; 345 (8) 568-573
76 Guerin C, Gaillard S, Lemasson S et al.. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA. 2004; 292 (19) 2379-2387
77 Davies A, Jones D, Bailey M Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009; 302 (17) 1888-1895
78 Napolitano L M, Park P K, Raghavendran K, Bartlett R H. Nonventilatory strategies for patients with life-threatening 2009 H1N1 influenza and severe respiratory failure. Crit Care Med. 2010; 38 (4, Suppl) e74-e90
79 Peek G J, Moore H M, Moore N, Sosnowski A W, Firmin R K. Extracorporeal membrane oxygenation for adult respiratory failure. Chest. 1997; 112 (3) 759-764
80 Hemmila M R, Rowe S A, Boules T N et al.. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg. 2004; 240 (4) 595-605 discussion 605-607
81 Peek G J, Mugford M, Tiruvoipati R CESAR trial collaboration et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009; 374 (9698) 1351-1363
82 Santos C D, Bristow R B, Vorenkamp J V. Which health care workers were most affected during the spring 2009 H1N1 pandemic?. Disaster Med Public Health Prep. 2010; 4 (1) 47-54
83 Poalillo F E, Geiling J, Jimenez E J. Healthcare personnel and nosocomial transmission of pandemic 2009 influenza. Crit Care Med. 2010; 38 (4, Suppl) e98-e102
84 Centers for Disease Control and Prevention (CDC) . Novel influenza A (H1N1) virus infections among health-care personnel—United States, April–May 2009. MMWR Morb Mortal Wkly Rep. 2009; 58 (23) 641-645
85 Loeb M B. Severe acute respiratory syndrome: preparedness, management, and impact. Infect Control Hosp Epidemiol. 2004; 25 (12) 1017-1019
86 Oberg T, Brosseau L M. Surgical mask filter and fit performance. Am J Infect Control. 2008; 36 (4) 276-282
87 Talbot T R, Crocker D D, Peters J et al.. Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults. Infect Control Hosp Epidemiol. 2005; 26 (5) 494-500
88 Wilde J A, McMillan J A, Serwint J, Butta J, O'Riordan M A, Steinhoff M C. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999; 281 (10) 908-913
89 Pandemic Influenza Resources. http://www.cdc.gov/flu/tools/flusurge.htm
90 Nap R E, Andriessen M P, Meessen N E, van der Werf T S. Pandemic influenza and hospital resources. Emerg Infect Dis. 2007; 13 (11) 1714-1719
91 Hota S, Fried E, Burry L, Stewart T E, Christian M D. Preparing your intensive care unit for the second wave of H1N1 and future surges. Crit Care Med. 2010; 38 (4, Suppl) e110-e119
92 Hick J L, Hanfling D, Burstein J L et al.. Health care facility and community strategies for patient care surge capacity. Ann Emerg Med. 2004; 44 (3) 253-261
93 Hick J L, Barbera J A, Kelen G D. Refining surge capacity: conventional, contingency, and crisis capacity. Disaster Med Public Health Prep. 2009; 3 (2, Suppl) S59-S67
94 Hanley M E, Bogdan G M. Mechanical ventilation in mass casualty scenarios. Augmenting staff: project XTREME. Respir Care. 2008; 53 (2) 176-188 discussion 189
95 Rubinson L, Hick J L, Curtis J R Task Force for Mass Critical Care et al. Definitive care for the critically ill during a disaster: medical resources for surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26–27, 2007, Chicago, IL. Chest. 2008; 133 (5, Suppl) 32S-50S

Glen P WestallM.B.B.S. Ph.D.

Department of Allergy, Immunology, and Respiratory Medicine, The Alfred Hospital

Commercial Rd., Melbourne, Vic 3181, Australia

Email: G.Westall@alfred.org.au